1. 2017
  2. Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies

    Keirsse, J., Van Damme, H., Van Ginderachter, J. A. & Laoui, D., Aug 2017, In : Journal of Leukocyte Biology. 102, 2, p. 317-324 8 p.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  3. Inactivation of γ-secretases leads to accumulation of substrates and non-Alzheimer neurodegeneration

    Acx, H., Serneels, L., Radaelli, E., Muyldermans, S., Vincke, C., Pepermans, E., Müller, U., Chávez-Gutiérrez, L. & De Strooper, B., Aug 2017, In : EMBO Molecular Medicine. 9, 8, p. 1088-1099 12 p.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Trypanosoma Infection Favors Brucella Elimination via IL-12/IFNγ-Dependent Pathways

    Machelart, A., Van Vyve, M., Potemberg, G., Demars, A., De Trez, C., Tima, H. G., Vanwalleghem, G., Romano, M., Truyens, C., Letesson, J-J. & Muraille, E., 31 Jul 2017, In : Frontiers in Immunology. 8, JUL, p. 903 903.

    Research output: Contribution to journalArticleResearchpeer-review

  5. I-131-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment

    D'Huyvetter, M., De Vos, J., Xavier, C., Pruszynski, M., Sterckx, Y. G. J., Massa, S., Raes, G., Caveliers, V., Zalutsky, M., Lahoutte, T. & Devoogdt, N., 27 Jul 2017, In : Clinical Cancer Research. 23, 21, p. 6616-6628 13 p.

    Research output: Contribution to journalArticleResearchpeer-review

  6. Trypanosoma brucei growth control by TNF in mammalian host is independent of the soluble form of the cytokine

    Vanwalleghem, G., Morias, Y., Beschin, A., Szymkowski, D. E. & Pays, E., 21 Jul 2017, In : Scientific Reports - Nature. 7, 1, p. 6165 6165.

    Research output: Contribution to journalArticleResearchpeer-review

  7. Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates

    Jovčevska, I., Zupanec, N., Urlep, Ž., Vranič, A., Matos, B., Stokin, C. L., Muyldermans, S., Myers, M. P., Buzdin, A. A., Petrov, I. & Komel, R., 4 Jul 2017, In : Oncotarget. 8, 27, p. 44141-44158 18 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis.

    Stijlemans, B., De Baetselier, P., Caljon, G., Van Den Abbeele, J., Van Ginderachter, J. & Magez, S., 30 Jun 2017, In : Frontiers in Immunology. 8, JUN, 12 p., 724.

    Research output: Contribution to journalArticleResearchpeer-review

  9. Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers

    Broos, K., Keyaerts, M., Lecocq, Q., Renmans, D., T, N., Escors, D., A., L., Raes, G., Breckpot, K. & Devoogdt, N., 27 Jun 2017, In : Oncotarget. 8, 26, p. 41932-41946 15 p.

    Research output: Contribution to journalArticleResearchpeer-review

  10. Ultrasensitive Measurement of Ca(2+) Influx into Lipid Vesicles Induced by Protein Aggregates

    Flagmeier, P., De, S., Wirthensohn, D. C., Lee, S. F., Vincke, C., Muyldermans, S., Knowles, T. P. J., Gandhi, S., Dobson, C. M. & Klenerman, D., 26 Jun 2017, In : Angewandte Chemie International Edition. 56, 27, p. 7750-7754 5 p.

    Research output: Contribution to journalArticleResearchpeer-review

  11. Functionalization of gold nanoparticles with nanobodies through physical adsorption

    Goossens, J., Sein, H., Lu, S., Radwanska, M., Muyldermans, S., Sterckx, Y. G. J. & Magez, S., 21 Jun 2017, In : Analytical Methods. 9, 23, p. 3430-3440 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1...5 6 7 8 9 10 11 12 ...67 Next